Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study.
Bobes
J
J
Medicine Department, Psychiatry Area, University of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, C/Julián Clavería, 6, 33006 Oviedo (Asturias), Spain. bobes@uniovi.es
Arango
C
C
Aranda
P
P
Carmena
R
R
Garcia-Garcia
M
M
Rejas
J
J
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D008076:Cholesterol, HDL / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D008875:Middle Aged; D015995:Prevalence; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D055105:Waist Circumference
D014150:Antipsychotic Agents; D008076:Cholesterol, HDL; D014280:Triglycerides